Literature DB >> 406137

Diurnal variation of valproic acid plasma levels and day-night reversal in monkey.

J S Lockard, R H Levy, L L DuCharme, W C Congdon, I H Patel.   

Abstract

Four normal monkeys each equipped with an EEG plug and two indwelling catheters for drug infusion and sampling, respectively, were administered valproic acid (VPA) before and after a 12-hr light, 12-hr dark phase shift. Before day-night reversal, diurnal oscillations of VPA plasma levels under steady-state intravenous constant-rate infusions were 30-50%, with maximum concentrations during the dark phase of the cycle. After reversal, maximum VPA plasma concentrations tended to follow the dark phase shift. The correlation was not perfect, nor was the sleep cycle completely reversed since the animals slept less after the phase shift. Possible mechanisms of the diurnal plasma level fluctuations and the importance of oscillations of this magnitude to clinical drug regimens are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 406137     DOI: 10.1111/j.1528-1157.1977.tb04466.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  4 in total

1.  Diurnal variation in cyclosporine kinetics.

Authors:  R Venkataramanan; S Yang; G J Burckart; R J Ptachcinski; D H Van Thiel; T E Starzl
Journal:  Ther Drug Monit       Date:  1986       Impact factor: 3.681

2.  Influence of pharmacokinetic diurnal variation on bioavailability estimates.

Authors:  L A Bauer; M Gibaldi; R E Vestal
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 3.  Time-dependence in benzodiazepine pharmacokinetics. Mechanisms and clinical significance.

Authors:  T W Guentert
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

4.  Diurnal variations in steady-state plasma concentrations of valproic acid in epileptic patients.

Authors:  P Loiseau; B Cenraud; R H Levy; R Akbaraly; A Brachet-Liermain; M Guyot; P L Morselli
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.